Touchlight DNA Services

Touchlight is an industry leader in synthetic DNA technology to enable the development of genetic medicines. We provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, AAV, lentivirus, non-viral gene therapy and DNA API. Services include DNA from research grade to GMP production.

Our novel, synthetic DNA vector – doggybone DNA (dbDNA™) is a minimal, linear, covalently closed structure, which eliminates bacterial sequences. Our revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies.

Customers can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house